<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107-vaccines-07-00074">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liao</surname>
    <given-names>H.-X.</given-names>
   </name>
   <name>
    <surname>Tsao</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Alam</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Muldoon</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Vandergrift</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>B.-J.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Sutherland</surname>
    <given-names>L.L.</given-names>
   </name>
   <name>
    <surname>Scearce</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Bowman</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1</article-title>
  <source>J. Virol.</source>
  <year>2013</year>
  <volume>87</volume>
  <fpage>4185</fpage>
  <lpage>4201</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02297-12</pub-id>
  <?supplied-pmid 23365441?>
  <pub-id pub-id-type="pmid">23365441</pub-id>
 </element-citation>
</ref>
